Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Vascular Inflammation in Psoriasis - Apremilast (VIP-A)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT03082729
Recruitment Status : Completed
First Posted : March 17, 2017
Last Update Posted : January 14, 2022
Celgene Corporation
National Heart, Lung, and Blood Institute (NHLBI)
Information provided by (Responsible Party):
University of Pennsylvania

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : August 17, 2021
Actual Study Completion Date : August 17, 2021